miR-195 in human primary mesenchymal stromal/stem cells regulates proliferation, osteogenesis and paracrine effect on angiogenesis-Reference-Cited by-同舟云学术

miR-195 in human primary mesenchymal stromal/stem cells regulates proliferation, osteogenesis and paracrine effect on angiogenesis

Published:2015-12-13 Issue:1 Volume:7 Page:7-22
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Almeida Maria Ines¹²,Silva Andreia Machado¹²³,Vasconcelos Daniel Marques¹²³,Almeida Catarina Rodrigues¹²,Caires Hugo¹²,Pinto Marta Teixeira¹⁴,Calin George Adrian⁵,Santos Susana Gomes¹²³,Barbosa Mário Adolfo¹²³

Affiliation:

1. Instituto de Investigação e Inovação em Saúde/Institute for Research and Innovation in Health (I3S), University of Porto, Porto, Portugal

2. Instituto de Engenharia Biomédica (INEB), University of Porto, Porto, Portugal

3. Instituto de Ciências Biomédicas Abel Salazar (ICBAS), University of Porto, Porto, Portugal

4. Institute of Molecular Pathology and Immunology of University of Porto (Ipatimup), Porto, Portugal

5. Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PD-1/PD-L1 Inhibitors for the Treatment of Lung Cancer;Immunotherapy Against Lung Cancer;2024

2. Hsa-miR-15b-5p/miR-195-5p Controls Osteogenic Differentiation of Human Adipose-Derived Mesenchymal Stem Cells Through Regulating Indian Hedgehog Expression;Applied Biochemistry and Biotechnology;2023-11-15

3. Senolytic drugs: implications for clinical practice;Problems of Geroscience;2023-09-11

4. Osteoblast-Derived Matrix Vesicles Exhibit Exosomal Traits and a Unique Subset of microRNA: Their Caveolae-Dependent Endocytosis Results in Reduced Osteogenic Differentiation;International Journal of Molecular Sciences;2023-08-14

5. Circulating microRNAs can predict chemotherapy-induced toxicities in patients being treated for primary breast cancer;Breast Cancer Research and Treatment;2023-08-04